{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:29:08Z","timestamp":1795058948483,"version":"4.10.2"},"reference-count":44,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T00:00:00Z","timestamp":1587168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"C&amp;K pharmaceuticals","award":["CKP, 2015002016X02"],"award-info":[{"award-number":["CKP, 2015002016X02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>This study was carried out to evaluate the vaccination effect of a virus-like particle (VLP) including the surface antigen 1 (SAG1) of Toxoplasma gondii as a potential vaccine for toxoplasmosis. The SAG1 virus-like particles (SAG1-VLPs) were expressed by Sf9 cells, and their expression was confirmed through cloning, RT-PCR analysis, and western blot method. The immunogenicity and vaccine efficacy of SAG1-VLPs were assessed by the antibody response, cytokine analysis, neutralization activity, splenocyte assay, and survival rates through a mouse model. In particular, IgG, IgG1, IgG2a, and IgA were markedly increased after immunization, and the survival rates of T. gondii were strongly inhibited by the immunized sera. Furthermore, the immunization of SAG1-VLPs effectively decreased the production of specific cytokines, such as IL-1\u03b2, IL-6, TNF-\u03b1, and IFN-\u03b3, after parasite infection. In particular, the immunized group showed strong activity and viability compared with the non-immunized infection group, and their survival rate was 75%. These results demonstrate that SAG1-VLP not only has the immunogenicity to block T. gondii infection by effectively inducing the generation of specific antibodies against T. gondii, but is also an effective antigen delivery system for preventing toxoplasmosis. This study indicates that SAG1-VLP can be effectively utilized as a promising vaccine candidate for preventing or inhibiting T. gondii infection.<\/jats:p>","DOI":"10.3390\/biomedicines8040091","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T03:23:06Z","timestamp":1587439386000},"page":"91","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Immunogenicity and Protective Effect of a Virus-Like Particle Containing the SAG1 Antigen of Toxoplasma gondii as a Potential Vaccine Candidate for Toxoplasmosis"],"prefix":"10.3390","volume":"8","author":[{"given":"Won Hyung","family":"Choi","sequence":"first","affiliation":[{"name":"Marine Bio Research &amp; Education Center, Kunsan National University, 558 Daehak-ro, Gunsan-si, Jeollabuk-do 54150, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Sun","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Chemistry, College of Natural Science, Kunsan National University, 558 Daehak-ro, Gunsan-si, Jeollabuk-do 54150, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Choi, W.H., and Lee, I.A. (2019). The Mechanism of Action of Ursolic Acid as a Potential Anti-Toxoplasmosis Agent, and Its Immunomodulatory Effects. Pathogens, 8.","DOI":"10.3390\/pathogens8020061"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e00409-17","DOI":"10.1128\/mSphere.00409-17","article-title":"Differential Roles for Inner Membrane Complex Proteins across Toxoplasma gondii and Sarcocystis neurona Development","volume":"2","author":"Dubey","year":"2017","journal-title":"mSphere"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/cmi.12285","article-title":"The inner membrane complex throughdevelopment of Toxoplasma gondii and Plasmodium","volume":"16","author":"Harding","year":"2014","journal-title":"Cell. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Beck, J.R., Rodriguez-Fernandez, I.A., de Leon, J.C., Huynh, M.H., Carruthers, V.B., Morrissette, N.S., and Bradley, P.J. (2010). A novel family of Toxoplasma IMCproteins displays a hierarchical organization and functions in coordinatingparasite division. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001094"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Choi, W.H., and Lee, I.A. (2018). Evaluation of Anti-Toxoplasma gondii Effect of Ursolic Acid as a Novel Toxoplasmosis Inhibitor. Pharmaceuticals, 11.","DOI":"10.3390\/ph11020043"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1128\/IAI.00782-08","article-title":"Intervacuolar Transport and Unique Topology of GRA14, a Novel Dense Granule Protein in Toxoplasma gondii","volume":"76","author":"Rome","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1574-6976.1999.tb00413.x","article-title":"Signaling during the invasion of host cells by Toxoplasma gondii","volume":"23","author":"Bonhomme","year":"1999","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fcimb.2019.00026","article-title":"Evaluation of ATM Kinase Inhibitor KU-55933 as Potential Anti-Toxoplasma gondii Agent","volume":"9","author":"Ganuza","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijpara.2017.12.006","article-title":"Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosis","volume":"48","author":"Moine","year":"2018","journal-title":"Int. J. Parasitol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijpddr.2018.02.006","article-title":"Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo","volume":"8","author":"Si","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Silveira, G.R., Campelo, K.A., Lima, G.R.S., Carvalho, L.P., Samarao, S.S., Vieira-da-Motta, O., Mathias, L., Matos, C.R.R., Vieira, I.J.C., and Melo, E.J.T. (2018). In Vitro Anti-Toxoplasma gondii and Antimicrobial Activity of Amides Derived from Cinnamic Acid. Molecules, 23.","DOI":"10.3390\/molecules23040774"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Alomar, M.L., Rasse-Suriani, F.O., Ganuza, A., Coceres, V.M., Cabrerizo, F.M., and Angel, S.O. (2013). In vitro evaluation of b-carboline alkaloids as potential anti-Toxoplasma agents. BMC Res. Notes, 6.","DOI":"10.1186\/1756-0500-6-193"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kavitha, N., Noordin, R., Chan, K.L., and Sasidharan, S. (2012). In vitro anti-Toxoplasma gondii activity of root extract\/fractions of Eurycoma longifolia Jack. BMC Complement. Altern. Med., 12.","DOI":"10.1186\/1472-6882-12-91"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.bbrc.2019.12.012","article-title":"Cephalotaxine inhibits Zika infection by impeding viral replication and stability","volume":"522","author":"Lai","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00436-019-06305-x","article-title":"The Drosophila melanogaster antimicrobial peptides Mtk-1 and Mtk-2 are active against the malarial parasite Plasmodium falciparum","volume":"118","author":"Tonk","year":"2019","journal-title":"Parasitol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1039\/C9CC01689A","article-title":"Close the ring to break the cycle: Tandem quinolone-alkyne-cyclisation gives access to tricyclic pyrrolo[1,2-a]quinolin-5-ones with potent anti-protozoal activity","volume":"55","author":"Szamosvari","year":"2019","journal-title":"Chem. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Choi, W.H. (2017). Novel pharmacological activity of artesunate and artemisinin: Their potential as anti-tubercular agents. J. Clin. Med., 6.","DOI":"10.3390\/jcm6030030"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpddr.2019.10.004","article-title":"Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB","volume":"11","author":"Reguera","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.apjtm.2016.01.021","article-title":"Evaluation of anti-tubercular activity of linolenic acid and conjugated-linoleic acid as effective inhibitors against Mycobacterium tuberculosis","volume":"9","author":"Choi","year":"2016","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zhang, W., Bailey-Elkin, B.A., Knaap, R.C.M., Khare, B., Dalebout, T.J., Johnson, G.G., van Kasteren, P.B., McLeish, N.J., Gu, J., and He, W. (2017). Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006372"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.virusres.2010.01.006","article-title":"Avian coronavirus infectious bronchitis virus susceptibility to botanical oleoresins and essential oils in vitro and in vivo","volume":"149","author":"Jackwood","year":"2010","journal-title":"Virus Res."},{"key":"ref_23","first-page":"1","article-title":"Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge","volume":"15","author":"Choi","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cell.2019.08.010","article-title":"Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans","volume":"178","author":"Hagan","year":"2019","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"eaaw7083","DOI":"10.1126\/sciimmunol.aaw7083","article-title":"Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes","volume":"4","author":"Awasthi","year":"2019","journal-title":"Sci. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"eaaw3163","DOI":"10.1126\/scitranslmed.aaw3163","article-title":"Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot","volume":"11","author":"Mateo","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"eaav4717","DOI":"10.1126\/scisignal.aav4717","article-title":"Amino acid starvation enhances vaccine efficacy by augmenting neutralizing antibody production","volume":"12","author":"Afroz","year":"2019","journal-title":"Sci. Signal."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41590-018-0235-7","article-title":"Recent progress in broadly neutralizing antibodies to HIV","volume":"19","author":"Sok","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/imr.12511","article-title":"Use of broadly neutralizing antibodies for HIV-1 prevention","volume":"275","author":"Pegu","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1701-2163(15)31053-7","article-title":"Society of Obstetricians and Gynaecologists of Canada. Toxoplasmosis in pregnancy: Prevention, screening, and treatment","volume":"35","author":"Paquet","year":"2013","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-0037-1603942","article-title":"Fetomaternal and Pediatric Toxoplasmosis","volume":"12","author":"Oz","year":"2017","journal-title":"J. Pediatr. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jiac.2019.06.012","article-title":"Seroprevalence and associated factors of Toxoplasma gondii among HIV-infected patients in Tokyo: A cross sectional study","volume":"26","author":"Hoshina","year":"2020","journal-title":"J. Infect. Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"E5344","DOI":"10.1073\/pnas.1801118115","article-title":"Encephalitis is mediated by ROP18 of Toxoplasma gondii, a severe pathogen in AIDS patients","volume":"115","author":"An","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev-micro-091014-104100","article-title":"Lytic Cycle of Toxoplasma gondii: 15 Years Later","volume":"69","author":"Blader","year":"2015","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e00579-17","DOI":"10.1128\/mBio.00579-17","article-title":"The Toxoplasma Centrocone Houses Cell Cycle Regulatory Factors","volume":"8","author":"Naumov","year":"2017","journal-title":"mBio"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fimmu.2018.00317","article-title":"Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis","volume":"9","author":"Lakhrif","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fmicb.2018.00909","article-title":"Immune Protection of Rhoptry Protein 21 (ROP21) of Toxoplasma gondii as a DNA Vaccine Against Toxoplasmosis","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1007\/s00436-015-4609-6","article-title":"MIC3, a novel cross-protective antigen expressed in Toxoplasma gondii and Neospora caninum","volume":"114","author":"Yang","year":"2015","journal-title":"Parasitol. Res."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Yang, L., Liang, H., Wang, B., Ma, B., Wang, J., and Zhang, W. (2020). Evaluation of the Potency of Two Pyolysin-Derived Recombinant Proteins as Vaccine Candidates of Trueperella Pyogenes in a Mouse Model: Pyolysin Oligomerization and Structural Change Affect the Efficacy of Pyolysin-Based Vaccines. Vaccines, 8.","DOI":"10.3390\/vaccines8010079"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.exppara.2012.02.026","article-title":"Toxoplasma gondii: The vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB\/c mice","volume":"131","author":"Dziadek","year":"2012","journal-title":"Exp. Parasitol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Gatkowska, J., Dzitko, K., Ferra, B.T., Holec-G\u0105sior, L., Kawka, M., and Dziadek, B. (2019). The Impact of the Antigenic Composition of Chimeric Proteins on Their Immunoprotective Activity against Chronic Toxoplasmosis in Mice. Vaccines, 7.","DOI":"10.3390\/vaccines7040154"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.parint.2017.06.002","article-title":"SAG5B and SAG5C combined vaccine protects mice against Toxoplasma gondii infection","volume":"66","author":"Lu","year":"2017","journal-title":"Parasitol. Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jmb.2005.09.028","article-title":"Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response","volume":"354","author":"Graille","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.exppara.2013.04.002","article-title":"Encapsulation of chimeric protein rSAG1\/2 into poly(lactide-co-glycolide) microparticles induces long-term protective immunity against Toxoplasma gondii in mice","volume":"134","author":"Chuang","year":"2013","journal-title":"Exp. Parasitol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/8\/4\/91\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:45:07Z","timestamp":1760363107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/8\/4\/91"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,18]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["biomedicines8040091"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines8040091","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,18]]}}}